The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Devices for Inhaled Medications Market Research Report 2025
Synopsis
Devices for Inhaled Medications are a class of medical devices used to deliver drugs into the patient's respiratory tract. These devices are designed to deliver medications into a patient's lungs in the form of an aerosol or powder, and are often used to treat respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and more.
The global Devices for Inhaled Medications market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Devices for Inhaled Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Devices for Inhaled Medications.
Report Scope
The Devices for Inhaled Medications market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Devices for Inhaled Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Devices for Inhaled Medications manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Consort Medical
Inhalexper
Cambridge Consultants
Hovione
Catalent, Inc
VertMarkets, Inc
Qualicaps
3M
Aerovance
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
Civitas/Alkermes
GlaxoSmithKline
Hovione
Mannkind
Mantecorp
Meda
MicroDose Therapeutx
Novartis
Segment by Type
Dry Powder Inhalers
Metered-Dose Inhalers
Nebulizers
Soft Mist Inhaler
Segment by Application
Clinic
Hospital
Household
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Devices for Inhaled Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Devices for Inhaled Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Devices for Inhaled Medications are a class of medical devices used to deliver drugs into the patient's respiratory tract. These devices are designed to deliver medications into a patient's lungs in the form of an aerosol or powder, and are often used to treat respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and more.
The global Devices for Inhaled Medications market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Devices for Inhaled Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Devices for Inhaled Medications.
Report Scope
The Devices for Inhaled Medications market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Devices for Inhaled Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Devices for Inhaled Medications manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Consort Medical
Inhalexper
Cambridge Consultants
Hovione
Catalent, Inc
VertMarkets, Inc
Qualicaps
3M
Aerovance
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
Civitas/Alkermes
GlaxoSmithKline
Hovione
Mannkind
Mantecorp
Meda
MicroDose Therapeutx
Novartis
Segment by Type
Dry Powder Inhalers
Metered-Dose Inhalers
Nebulizers
Soft Mist Inhaler
Segment by Application
Clinic
Hospital
Household
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Devices for Inhaled Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Devices for Inhaled Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Devices for Inhaled Medications Market Overview
1.1 Product Overview and Scope of Devices for Inhaled Medications
1.2 Devices for Inhaled Medications Segment by Type
1.2.1 Global Devices for Inhaled Medications Market Value Comparison by Type (2024-2030)
1.2.2 Dry Powder Inhalers
1.2.3 Metered-Dose Inhalers
1.2.4 Nebulizers
1.2.5 Soft Mist Inhaler
1.3 Devices for Inhaled Medications Segment by Application
1.3.1 Global Devices for Inhaled Medications Market Value by Application: (2024-2030)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Household
1.4 Global Devices for Inhaled Medications Market Size Estimates and Forecasts
1.4.1 Global Devices for Inhaled Medications Revenue 2019-2030
1.4.2 Global Devices for Inhaled Medications Sales 2019-2030
1.4.3 Global Devices for Inhaled Medications Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Devices for Inhaled Medications Market Competition by Manufacturers
2.1 Global Devices for Inhaled Medications Sales Market Share by Manufacturers (2019-2024)
2.2 Global Devices for Inhaled Medications Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Devices for Inhaled Medications Average Price by Manufacturers (2019-2024)
2.4 Global Devices for Inhaled Medications Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Devices for Inhaled Medications, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Devices for Inhaled Medications, Product Type & Application
2.7 Devices for Inhaled Medications Market Competitive Situation and Trends
2.7.1 Devices for Inhaled Medications Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Devices for Inhaled Medications Players Market Share by Revenue
2.7.3 Global Devices for Inhaled Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Devices for Inhaled Medications Retrospective Market Scenario by Region
3.1 Global Devices for Inhaled Medications Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Devices for Inhaled Medications Global Devices for Inhaled Medications Sales by Region: 2019-2030
3.2.1 Global Devices for Inhaled Medications Sales by Region: 2019-2024
3.2.2 Global Devices for Inhaled Medications Sales by Region: 2025-2030
3.3 Global Devices for Inhaled Medications Global Devices for Inhaled Medications Revenue by Region: 2019-2030
3.3.1 Global Devices for Inhaled Medications Revenue by Region: 2019-2024
3.3.2 Global Devices for Inhaled Medications Revenue by Region: 2025-2030
3.4 North America Devices for Inhaled Medications Market Facts & Figures by Country
3.4.1 North America Devices for Inhaled Medications Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Devices for Inhaled Medications Sales by Country (2019-2030)
3.4.3 North America Devices for Inhaled Medications Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Devices for Inhaled Medications Market Facts & Figures by Country
3.5.1 Europe Devices for Inhaled Medications Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Devices for Inhaled Medications Sales by Country (2019-2030)
3.5.3 Europe Devices for Inhaled Medications Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Devices for Inhaled Medications Market Facts & Figures by Country
3.6.1 Asia Pacific Devices for Inhaled Medications Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Devices for Inhaled Medications Sales by Country (2019-2030)
3.6.3 Asia Pacific Devices for Inhaled Medications Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Devices for Inhaled Medications Market Facts & Figures by Country
3.7.1 Latin America Devices for Inhaled Medications Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Devices for Inhaled Medications Sales by Country (2019-2030)
3.7.3 Latin America Devices for Inhaled Medications Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Devices for Inhaled Medications Market Facts & Figures by Country
3.8.1 Middle East and Africa Devices for Inhaled Medications Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Devices for Inhaled Medications Sales by Country (2019-2030)
3.8.3 Middle East and Africa Devices for Inhaled Medications Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Devices for Inhaled Medications Sales by Type (2019-2030)
4.1.1 Global Devices for Inhaled Medications Sales by Type (2019-2024)
4.1.2 Global Devices for Inhaled Medications Sales by Type (2025-2030)
4.1.3 Global Devices for Inhaled Medications Sales Market Share by Type (2019-2030)
4.2 Global Devices for Inhaled Medications Revenue by Type (2019-2030)
4.2.1 Global Devices for Inhaled Medications Revenue by Type (2019-2024)
4.2.2 Global Devices for Inhaled Medications Revenue by Type (2025-2030)
4.2.3 Global Devices for Inhaled Medications Revenue Market Share by Type (2019-2030)
4.3 Global Devices for Inhaled Medications Price by Type (2019-2030)
5 Segment by Application
5.1 Global Devices for Inhaled Medications Sales by Application (2019-2030)
5.1.1 Global Devices for Inhaled Medications Sales by Application (2019-2024)
5.1.2 Global Devices for Inhaled Medications Sales by Application (2025-2030)
5.1.3 Global Devices for Inhaled Medications Sales Market Share by Application (2019-2030)
5.2 Global Devices for Inhaled Medications Revenue by Application (2019-2030)
5.2.1 Global Devices for Inhaled Medications Revenue by Application (2019-2024)
5.2.2 Global Devices for Inhaled Medications Revenue by Application (2025-2030)
5.2.3 Global Devices for Inhaled Medications Revenue Market Share by Application (2019-2030)
5.3 Global Devices for Inhaled Medications Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Consort Medical
6.1.1 Consort Medical Corporation Information
6.1.2 Consort Medical Description and Business Overview
6.1.3 Consort Medical Devices for Inhaled Medications Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Consort Medical Devices for Inhaled Medications Product Portfolio
6.1.5 Consort Medical Recent Developments/Updates
6.2 Inhalexper
6.2.1 Inhalexper Corporation Information
6.2.2 Inhalexper Description and Business Overview
6.2.3 Inhalexper Devices for Inhaled Medications Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Inhalexper Devices for Inhaled Medications Product Portfolio
6.2.5 Inhalexper Recent Developments/Updates
6.3 Cambridge Consultants
6.3.1 Cambridge Consultants Corporation Information
6.3.2 Cambridge Consultants Description and Business Overview
6.3.3 Cambridge Consultants Devices for Inhaled Medications Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cambridge Consultants Devices for Inhaled Medications Product Portfolio
6.3.5 Cambridge Consultants Recent Developments/Updates
6.4 Hovione
6.4.1 Hovione Corporation Information
6.4.2 Hovione Description and Business Overview
6.4.3 Hovione Devices for Inhaled Medications Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hovione Devices for Inhaled Medications Product Portfolio
6.4.5 Hovione Recent Developments/Updates
6.5 Catalent, Inc
6.5.1 Catalent, Inc Corporation Information
6.5.2 Catalent, Inc Description and Business Overview
6.5.3 Catalent, Inc Devices for Inhaled Medications Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Catalent, Inc Devices for Inhaled Medications Product Portfolio
6.5.5 Catalent, Inc Recent Developments/Updates
6.6 VertMarkets, Inc
6.6.1 VertMarkets, Inc Corporation Information
6.6.2 VertMarkets, Inc Description and Business Overview
6.6.3 VertMarkets, Inc Devices for Inhaled Medications Sales, Revenue and Gross Margin (2019-2024)
6.6.4 VertMarkets, Inc Devices for Inhaled Medications Product Portfolio
6.6.5 VertMarkets, Inc Recent Developments/Updates
6.7 Qualicaps
6.6.1 Qualicaps Corporation Information
6.6.2 Qualicaps Description and Business Overview
6.6.3 Qualicaps Devices for Inhaled Medications Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Qualicaps Devices for Inhaled Medications Product Portfolio
6.7.5 Qualicaps Recent Developments/Updates
6.8 3M
6.8.1 3M Corporation Information
6.8.2 3M Description and Business Overview
6.8.3 3M Devices for Inhaled Medications Sales, Revenue and Gross Margin (2019-2024)
6.8.4 3M Devices for Inhaled Medications Product Portfolio
6.8.5 3M Recent Developments/Updates
6.9 Aerovance
6.9.1 Aerovance Corporation Information
6.9.2 Aerovance Description and Business Overview
6.9.3 Aerovance Devices for Inhaled Medications Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Aerovance Devices for Inhaled Medications Product Portfolio
6.9.5 Aerovance Recent Developments/Updates
6.10 AstraZeneca
6.10.1 AstraZeneca Corporation Information
6.10.2 AstraZeneca Description and Business Overview
6.10.3 AstraZeneca Devices for Inhaled Medications Sales, Revenue and Gross Margin (2019-2024)
6.10.4 AstraZeneca Devices for Inhaled Medications Product Portfolio
6.10.5 AstraZeneca Recent Developments/Updates
6.11 Boehringer Ingelheim
6.11.1 Boehringer Ingelheim Corporation Information
6.11.2 Boehringer Ingelheim Devices for Inhaled Medications Description and Business Overview
6.11.3 Boehringer Ingelheim Devices for Inhaled Medications Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Boehringer Ingelheim Devices for Inhaled Medications Product Portfolio
6.11.5 Boehringer Ingelheim Recent Developments/Updates
6.12 Chiesi
6.12.1 Chiesi Corporation Information
6.12.2 Chiesi Devices for Inhaled Medications Description and Business Overview
6.12.3 Chiesi Devices for Inhaled Medications Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Chiesi Devices for Inhaled Medications Product Portfolio
6.12.5 Chiesi Recent Developments/Updates
6.13 Cipla
6.13.1 Cipla Corporation Information
6.13.2 Cipla Devices for Inhaled Medications Description and Business Overview
6.13.3 Cipla Devices for Inhaled Medications Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Cipla Devices for Inhaled Medications Product Portfolio
6.13.5 Cipla Recent Developments/Updates
6.14 Civitas/Alkermes
6.14.1 Civitas/Alkermes Corporation Information
6.14.2 Civitas/Alkermes Devices for Inhaled Medications Description and Business Overview
6.14.3 Civitas/Alkermes Devices for Inhaled Medications Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Civitas/Alkermes Devices for Inhaled Medications Product Portfolio
6.14.5 Civitas/Alkermes Recent Developments/Updates
6.15 GlaxoSmithKline
6.15.1 GlaxoSmithKline Corporation Information
6.15.2 GlaxoSmithKline Devices for Inhaled Medications Description and Business Overview
6.15.3 GlaxoSmithKline Devices for Inhaled Medications Sales, Revenue and Gross Margin (2019-2024)
6.15.4 GlaxoSmithKline Devices for Inhaled Medications Product Portfolio
6.15.5 GlaxoSmithKline Recent Developments/Updates
6.16 Hovione
6.16.1 Hovione Corporation Information
6.16.2 Hovione Devices for Inhaled Medications Description and Business Overview
6.16.3 Hovione Devices for Inhaled Medications Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Hovione Devices for Inhaled Medications Product Portfolio
6.16.5 Hovione Recent Developments/Updates
6.17 Mannkind
6.17.1 Mannkind Corporation Information
6.17.2 Mannkind Devices for Inhaled Medications Description and Business Overview
6.17.3 Mannkind Devices for Inhaled Medications Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Mannkind Devices for Inhaled Medications Product Portfolio
6.17.5 Mannkind Recent Developments/Updates
6.18 Mantecorp
6.18.1 Mantecorp Corporation Information
6.18.2 Mantecorp Devices for Inhaled Medications Description and Business Overview
6.18.3 Mantecorp Devices for Inhaled Medications Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Mantecorp Devices for Inhaled Medications Product Portfolio
6.18.5 Mantecorp Recent Developments/Updates
6.19 Meda
6.19.1 Meda Corporation Information
6.19.2 Meda Devices for Inhaled Medications Description and Business Overview
6.19.3 Meda Devices for Inhaled Medications Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Meda Devices for Inhaled Medications Product Portfolio
6.19.5 Meda Recent Developments/Updates
6.20 MicroDose Therapeutx
6.20.1 MicroDose Therapeutx Corporation Information
6.20.2 MicroDose Therapeutx Devices for Inhaled Medications Description and Business Overview
6.20.3 MicroDose Therapeutx Devices for Inhaled Medications Sales, Revenue and Gross Margin (2019-2024)
6.20.4 MicroDose Therapeutx Devices for Inhaled Medications Product Portfolio
6.20.5 MicroDose Therapeutx Recent Developments/Updates
6.21 Novartis
6.21.1 Novartis Corporation Information
6.21.2 Novartis Devices for Inhaled Medications Description and Business Overview
6.21.3 Novartis Devices for Inhaled Medications Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Novartis Devices for Inhaled Medications Product Portfolio
6.21.5 Novartis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Devices for Inhaled Medications Industry Chain Analysis
7.2 Devices for Inhaled Medications Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Devices for Inhaled Medications Production Mode & Process
7.4 Devices for Inhaled Medications Sales and Marketing
7.4.1 Devices for Inhaled Medications Sales Channels
7.4.2 Devices for Inhaled Medications Distributors
7.5 Devices for Inhaled Medications Customers
8 Devices for Inhaled Medications Market Dynamics
8.1 Devices for Inhaled Medications Industry Trends
8.2 Devices for Inhaled Medications Market Drivers
8.3 Devices for Inhaled Medications Market Challenges
8.4 Devices for Inhaled Medications Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Devices for Inhaled Medications Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Devices for Inhaled Medications Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Devices for Inhaled Medications Market Competitive Situation by Manufacturers in 2023
Table 4. Global Devices for Inhaled Medications Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Devices for Inhaled Medications Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Devices for Inhaled Medications Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Devices for Inhaled Medications Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Devices for Inhaled Medications Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Devices for Inhaled Medications, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Devices for Inhaled Medications, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Devices for Inhaled Medications, Product Type & Application
Table 12. Global Key Manufacturers of Devices for Inhaled Medications, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Devices for Inhaled Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Devices for Inhaled Medications as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Devices for Inhaled Medications Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Devices for Inhaled Medications Sales by Region (2019-2024) & (K Units)
Table 18. Global Devices for Inhaled Medications Sales Market Share by Region (2019-2024)
Table 19. Global Devices for Inhaled Medications Sales by Region (2025-2030) & (K Units)
Table 20. Global Devices for Inhaled Medications Sales Market Share by Region (2025-2030)
Table 21. Global Devices for Inhaled Medications Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Devices for Inhaled Medications Revenue Market Share by Region (2019-2024)
Table 23. Global Devices for Inhaled Medications Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Devices for Inhaled Medications Revenue Market Share by Region (2025-2030)
Table 25. North America Devices for Inhaled Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Devices for Inhaled Medications Sales by Country (2019-2024) & (K Units)
Table 27. North America Devices for Inhaled Medications Sales by Country (2025-2030) & (K Units)
Table 28. North America Devices for Inhaled Medications Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Devices for Inhaled Medications Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Devices for Inhaled Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Devices for Inhaled Medications Sales by Country (2019-2024) & (K Units)
Table 32. Europe Devices for Inhaled Medications Sales by Country (2025-2030) & (K Units)
Table 33. Europe Devices for Inhaled Medications Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Devices for Inhaled Medications Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Devices for Inhaled Medications Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Devices for Inhaled Medications Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Devices for Inhaled Medications Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Devices for Inhaled Medications Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Devices for Inhaled Medications Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Devices for Inhaled Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Devices for Inhaled Medications Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Devices for Inhaled Medications Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Devices for Inhaled Medications Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Devices for Inhaled Medications Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Devices for Inhaled Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Devices for Inhaled Medications Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Devices for Inhaled Medications Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Devices for Inhaled Medications Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Devices for Inhaled Medications Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Devices for Inhaled Medications Sales (K Units) by Type (2019-2024)
Table 51. Global Devices for Inhaled Medications Sales (K Units) by Type (2025-2030)
Table 52. Global Devices for Inhaled Medications Sales Market Share by Type (2019-2024)
Table 53. Global Devices for Inhaled Medications Sales Market Share by Type (2025-2030)
Table 54. Global Devices for Inhaled Medications Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Devices for Inhaled Medications Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Devices for Inhaled Medications Revenue Market Share by Type (2019-2024)
Table 57. Global Devices for Inhaled Medications Revenue Market Share by Type (2025-2030)
Table 58. Global Devices for Inhaled Medications Price (USD/Unit) by Type (2019-2024)
Table 59. Global Devices for Inhaled Medications Price (USD/Unit) by Type (2025-2030)
Table 60. Global Devices for Inhaled Medications Sales (K Units) by Application (2019-2024)
Table 61. Global Devices for Inhaled Medications Sales (K Units) by Application (2025-2030)
Table 62. Global Devices for Inhaled Medications Sales Market Share by Application (2019-2024)
Table 63. Global Devices for Inhaled Medications Sales Market Share by Application (2025-2030)
Table 64. Global Devices for Inhaled Medications Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Devices for Inhaled Medications Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Devices for Inhaled Medications Revenue Market Share by Application (2019-2024)
Table 67. Global Devices for Inhaled Medications Revenue Market Share by Application (2025-2030)
Table 68. Global Devices for Inhaled Medications Price (USD/Unit) by Application (2019-2024)
Table 69. Global Devices for Inhaled Medications Price (USD/Unit) by Application (2025-2030)
Table 70. Consort Medical Corporation Information
Table 71. Consort Medical Description and Business Overview
Table 72. Consort Medical Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Consort Medical Devices for Inhaled Medications Product
Table 74. Consort Medical Recent Developments/Updates
Table 75. Inhalexper Corporation Information
Table 76. Inhalexper Description and Business Overview
Table 77. Inhalexper Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Inhalexper Devices for Inhaled Medications Product
Table 79. Inhalexper Recent Developments/Updates
Table 80. Cambridge Consultants Corporation Information
Table 81. Cambridge Consultants Description and Business Overview
Table 82. Cambridge Consultants Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Cambridge Consultants Devices for Inhaled Medications Product
Table 84. Cambridge Consultants Recent Developments/Updates
Table 85. Hovione Corporation Information
Table 86. Hovione Description and Business Overview
Table 87. Hovione Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Hovione Devices for Inhaled Medications Product
Table 89. Hovione Recent Developments/Updates
Table 90. Catalent, Inc Corporation Information
Table 91. Catalent, Inc Description and Business Overview
Table 92. Catalent, Inc Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Catalent, Inc Devices for Inhaled Medications Product
Table 94. Catalent, Inc Recent Developments/Updates
Table 95. VertMarkets, Inc Corporation Information
Table 96. VertMarkets, Inc Description and Business Overview
Table 97. VertMarkets, Inc Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. VertMarkets, Inc Devices for Inhaled Medications Product
Table 99. VertMarkets, Inc Recent Developments/Updates
Table 100. Qualicaps Corporation Information
Table 101. Qualicaps Description and Business Overview
Table 102. Qualicaps Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Qualicaps Devices for Inhaled Medications Product
Table 104. Qualicaps Recent Developments/Updates
Table 105. 3M Corporation Information
Table 106. 3M Description and Business Overview
Table 107. 3M Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. 3M Devices for Inhaled Medications Product
Table 109. 3M Recent Developments/Updates
Table 110. Aerovance Corporation Information
Table 111. Aerovance Description and Business Overview
Table 112. Aerovance Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Aerovance Devices for Inhaled Medications Product
Table 114. Aerovance Recent Developments/Updates
Table 115. AstraZeneca Corporation Information
Table 116. AstraZeneca Description and Business Overview
Table 117. AstraZeneca Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. AstraZeneca Devices for Inhaled Medications Product
Table 119. AstraZeneca Recent Developments/Updates
Table 120. Boehringer Ingelheim Corporation Information
Table 121. Boehringer Ingelheim Description and Business Overview
Table 122. Boehringer Ingelheim Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Boehringer Ingelheim Devices for Inhaled Medications Product
Table 124. Boehringer Ingelheim Recent Developments/Updates
Table 125. Chiesi Corporation Information
Table 126. Chiesi Description and Business Overview
Table 127. Chiesi Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Chiesi Devices for Inhaled Medications Product
Table 129. Chiesi Recent Developments/Updates
Table 130. Cipla Corporation Information
Table 131. Cipla Description and Business Overview
Table 132. Cipla Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Cipla Devices for Inhaled Medications Product
Table 134. Cipla Recent Developments/Updates
Table 135. Civitas/Alkermes Corporation Information
Table 136. Civitas/Alkermes Description and Business Overview
Table 137. Civitas/Alkermes Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Civitas/Alkermes Devices for Inhaled Medications Product
Table 139. Civitas/Alkermes Recent Developments/Updates
Table 140. GlaxoSmithKline Corporation Information
Table 141. GlaxoSmithKline Description and Business Overview
Table 142. GlaxoSmithKline Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. GlaxoSmithKline Devices for Inhaled Medications Product
Table 144. GlaxoSmithKline Recent Developments/Updates
Table 145. Hovione Corporation Information
Table 146. Hovione Description and Business Overview
Table 147. Hovione Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 148. Hovione Devices for Inhaled Medications Product
Table 149. Hovione Recent Developments/Updates
Table 150. Mannkind Corporation Information
Table 151. Mannkind Description and Business Overview
Table 152. Mannkind Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 153. Mannkind Devices for Inhaled Medications Product
Table 154. Mannkind Recent Developments/Updates
Table 155. Mantecorp Corporation Information
Table 156. Mantecorp Description and Business Overview
Table 157. Mantecorp Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 158. Mantecorp Devices for Inhaled Medications Product
Table 159. Mantecorp Recent Developments/Updates
Table 160. Meda Corporation Information
Table 161. Meda Description and Business Overview
Table 162. Meda Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 163. Meda Devices for Inhaled Medications Product
Table 164. Meda Recent Developments/Updates
Table 165. MicroDose Therapeutx Corporation Information
Table 166. MicroDose Therapeutx Description and Business Overview
Table 167. MicroDose Therapeutx Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 168. MicroDose Therapeutx Devices for Inhaled Medications Product
Table 169. MicroDose Therapeutx Recent Developments/Updates
Table 170. Novartis Corporation Information
Table 171. Novartis Description and Business Overview
Table 172. Novartis Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 173. Novartis Devices for Inhaled Medications Product
Table 174. Novartis Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Devices for Inhaled Medications Distributors List
Table 178. Devices for Inhaled Medications Customers List
Table 179. Devices for Inhaled Medications Market Trends
Table 180. Devices for Inhaled Medications Market Drivers
Table 181. Devices for Inhaled Medications Market Challenges
Table 182. Devices for Inhaled Medications Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Devices for Inhaled Medications
Figure 2. Global Devices for Inhaled Medications Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Devices for Inhaled Medications Market Share by Type in 2023 & 2030
Figure 4. Dry Powder Inhalers Product Picture
Figure 5. Metered-Dose Inhalers Product Picture
Figure 6. Nebulizers Product Picture
Figure 7. Soft Mist Inhaler Product Picture
Figure 8. Global Devices for Inhaled Medications Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Devices for Inhaled Medications Market Share by Application in 2023 & 2030
Figure 10. Clinic
Figure 11. Hospital
Figure 12. Household
Figure 13. Global Devices for Inhaled Medications Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Devices for Inhaled Medications Market Size (2019-2030) & (US$ Million)
Figure 15. Global Devices for Inhaled Medications Sales (2019-2030) & (K Units)
Figure 16. Global Devices for Inhaled Medications Average Price (USD/Unit) & (2019-2030)
Figure 17. Devices for Inhaled Medications Report Years Considered
Figure 18. Devices for Inhaled Medications Sales Share by Manufacturers in 2023
Figure 19. Global Devices for Inhaled Medications Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Devices for Inhaled Medications Players: Market Share by Revenue in 2023
Figure 21. Devices for Inhaled Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Devices for Inhaled Medications Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Devices for Inhaled Medications Sales Market Share by Country (2019-2030)
Figure 24. North America Devices for Inhaled Medications Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Devices for Inhaled Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Devices for Inhaled Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Devices for Inhaled Medications Sales Market Share by Country (2019-2030)
Figure 28. Europe Devices for Inhaled Medications Revenue Market Share by Country (2019-2030)
Figure 29. Germany Devices for Inhaled Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Devices for Inhaled Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Devices for Inhaled Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Devices for Inhaled Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Devices for Inhaled Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Devices for Inhaled Medications Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Devices for Inhaled Medications Revenue Market Share by Region (2019-2030)
Figure 36. China Devices for Inhaled Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Devices for Inhaled Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Devices for Inhaled Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Devices for Inhaled Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Devices for Inhaled Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Devices for Inhaled Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Devices for Inhaled Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Devices for Inhaled Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Devices for Inhaled Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Devices for Inhaled Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Devices for Inhaled Medications Sales Market Share by Country (2019-2030)
Figure 47. Latin America Devices for Inhaled Medications Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Devices for Inhaled Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Devices for Inhaled Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Devices for Inhaled Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Devices for Inhaled Medications Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Devices for Inhaled Medications Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Devices for Inhaled Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Devices for Inhaled Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. U.A.E Devices for Inhaled Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Devices for Inhaled Medications by Type (2019-2030)
Figure 57. Global Revenue Market Share of Devices for Inhaled Medications by Type (2019-2030)
Figure 58. Global Devices for Inhaled Medications Price (USD/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Devices for Inhaled Medications by Application (2019-2030)
Figure 60. Global Revenue Market Share of Devices for Inhaled Medications by Application (2019-2030)
Figure 61. Global Devices for Inhaled Medications Price (USD/Unit) by Application (2019-2030)
Figure 62. Devices for Inhaled Medications Value Chain
Figure 63. Devices for Inhaled Medications Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
